Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life

• Main Authors: Luca Cegolon (Author), Riccardo Pol (Author), Omar Simonetti (Author), Francesca Larese Filon (Author), Roberto Luzzati (Author)
• Format: Bog
• Udgivet: MDPI AG, 2023-05-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

<b>Background</b>. Several drugs which are easy to administer in outpatient settings have been authorized and endorsed for high-risk COVID-19 patients with mild-moderate disease to prevent hospital admission and death, complementing COVID-19 vaccines. However, the evidence on the efficac...